Recipient of federal assistance · CAMBRIDGE, MA

GENTIBIO, INC.

GENTIBIO, INC. received $4.4M in federal grants and other assistance in FY2026, on 6 actions, +285% vs FY2025. It has no federal contracts in the loaded years. Since FY2025: $5.6M. Its largest awarding agency was National Institutes of Health ($3.6M).

Assistance · FY2026
$4.4M
New awards
4
Actions
6
Since FY2025
$5.6M
UEI
HNHTFLZ9U5D4
Location
CAMBRIDGE, MA
Businesses
Open in the explorerFederal grants & assistance

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

Assistance by fiscal year

  1. 1.2MFY2025
  2. 4.4MFY2026

By type

  1. Grants$4.4M100%

Top programs · Awarding agencies

Obligations in FY2026.

Top programs

  1. 93.847 · Diabetes, Digestive, and Kidney Diseases Extramural Research$2.1M48%
  2. 93.853 · Extramural Research Programs in the Neurosciences and Neurological Disorders$1.5M33%
  3. 12.420 · Military Medical Research and Development$825.8K19%

Awarding agencies

  1. National Institutes of Health$3.6M81%
    Department of Health and Human Services
  2. Defense Health Agency$825.8K19%
    Department of Defense

Largest awards

  1. DEVELOPMENT OF TISSUE ENGINEERED TREGS AS A TREATMENT FOR ACUTE ISCHEMIC STROKE - ABSTRACT IN THE U.S., NEARLY 800,000 INDIVIDUALS…$2.3M
    93.853 · Extramural Research Programs in the Neurosciences and Neurological Disorders· National Institutes of Health· Project grant· Aug 19, 2025 – Jul 8, 2026· R44NS145848
  2. GNTI-148: AN ALLOGENEIC ISLET-SPECIFIC ENGINEERED TREG FOR TREATING T1D - ABSTRACT TYPE 1 DIABETES (T1D) IS A CHRONIC AUTOIMMUNE DISEASE…$1.1M
    93.847 · Diabetes, Digestive, and Kidney Diseases Extramural Research· National Institutes of Health· Project grant· Aug 24, 2026 – Sep 23, 2026· R44DK148168
  3. AN ALLOGENEIC AND GUT SPECIFIC ENGINEERED T REGULATORY CELL THERAPY FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE - ABSTRACT INFLAMMATORY…$1.1M
    93.847 · Diabetes, Digestive, and Kidney Diseases Extramural Research· National Institutes of Health· Project grant· Sep 17, 2026 – Sep 17, 2026· R44DK148134
  4. TISSUE-ENGINEERED TREGS FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS$825.8K
    12.420 · Military Medical Research and Development· Defense Health Agency· Project grant· Apr 3, 2026 – Apr 3, 2026· HT9425261E077
  5. ENGINEERED TISSUE TREG THERAPY FOR THE TREATMENT OF ALS - ABSTRACT/SUMMARY ALS IS A DEVASTATING NEURODEGENERATIVE DISEASE THAT…$320K
    93.853 · Extramural Research Programs in the Neurosciences and Neurological Disorders· National Institutes of Health· Project grant· Sep 7, 2026 – Sep 7, 2026· R43NS149828

Subawards

Matched by Unique Entity ID: the first-tier subawards this organization reported as a prime recipient, and those primes reported paying it.

As a prime: who it pays · FY2026

  • Sub-grants: $400.2K (2 subawards)

2 sub-recipients

  1. UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION$251.6K63%
    PITTSBURGH, PA · 1 subaward
  2. THE ADMINISTRATORS OF TULANE EDUCATIONAL FUND$148.6K37%
    NEW ORLEANS, LA · 1 subaward

As a sub-recipient: who pays it · FY2026

No subawards reported to it in FY2026.

Primes report first-tier subawards of $30,000 or more themselves, and many go unreported (GAO-24-106214). Reporting moved from FSRS to SAM.gov in March 2025 and fewer sub-contracts have been reported since. Amounts are what primes reported; they are never added to prime award totals.

Source: Subawards (first-tier sub-contracts and sub-grants reported under FFATA) (U.S. Department of the Treasury, USAspending.gov (reports filed in SAM.gov, formerly FSRS)), data current to Oct 9, 2026, loaded Oct 9, 2026 · Subawards loaded from FY2021.

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2025–FY2026.